Melanoma is, sadly, a problem that is “growing” on more and more Australians. ACMAV held a refresher seminar on this topic and also covered recent advances in melanoma management.
Our guest speakers were Surgeons Nicole Yap, David Gyorki, Medical Oncologist Annie Wong, Radiation Oncologist Jacki Doughton, and Patient Advocate Paul White.
As a special treat, member Jason Chuen brought along some 3D-printed models!
Note: This seminar was supported by MSD Australia, distributors of pembrolizumab (Keytruda®), a new targeted anti-PD1 immunotherapy for metastatic melanoma which has been temporarily approved for use under the PBS under the Managed Entry Scheme (MES).